Laboratory findings | Disease severity of COVID-19 | Statistic parameter | |||
---|---|---|---|---|---|
(mean ± SD) | AS (n = 11) | MS (n = 26) | SCS (n = 11) | F value | P value |
Ct values | 29.9 ± 2.4 | 30.4 ± 1.9 | 31.5 ± 1.5 | 2.186 | 0.061 |
B cells (%) | 15.0 ± 9.9 | 11.5 ± 7.0 | 4.0 ± 3.2 | 7.017 | 0.002** |
NK cells (%) | 9.8 ± 20.9 | 3.9 ± 2.9 | 3.4 ± 1.2 | 1.284 | 0.285 |
CD3 + T cells (%) | 69.7 ± 9.9 | 62.7 ± 9.1 | 54.7 ± 13.9 | 5.640 | 0.007** |
CD3 + CD4 + T cells (%) | 37.5 ± 10.3 | 40.1 ± 7.9 | 31.6 ± 104 | 3.327 | 0.045* |
CD3 + CD8 + T cells (%) | 23.1 ± 6.3 | 24.2 ± 10.5 | 17.0 ± 5.6 | 5.315 | 0.008** |
CD4 + /CD8 + ratio (%) | 1.7 ± 1.3 | 2.3 ± 1.1 | 2.0 ± 0.9 | 1.219 | 0.305 |
IL2 (pg/mL) | 5.4 ± 3.9 | 3.9 ± 3.6 | 6.7 ± 5.6 | 1.805 | 0.176 |
IL4 (pg/mL) | 9.27 ± 20.9 | 3.9 ± 3.6 | 6.7 ± 5.6 | 1.335 | 0.273 |
IL5 (pg/mL) | 6.7 ± 8.3 | 5.3 ± 5.6 | 5.8 ± 5.2 | 0.197 | 0.822 |
IL6 (pg/mL) | 12.3 ± 18.4 | 6.1 ± 12.5 | 574.9 ± 1325.4 | 3.389 | 0.039* |
IL8 (pg/mL) | 132.5 ± 114.4 | 33.5 ± 43.7 | 869.7 ± 1927.2 | 3.374 | 0.043* |
IL10 (pg/mL) | 2.9 ± 1.1 | 2.7 ± 1.2 | 7.4 ± 7.5 | 6.525 | 0.003** |
TNF-α (pg/mL) | 30.9 ± 28.9 | 25.5 ± 38.0 | 15.2 ± 24.2 | 0.639 | 0.533 |
INF-α (pg/mL) | 5.7 ± 9.3 | 4.7 ± 6.4 | 3.3 ± 0.8 | 0.380 | 0.686 |
INF-γ (pg/mL) | 12.4 ± 24.0 | 19.2 ± 48.7 | 11.7 ± 8.7 | 0.211 | 0.810 |